FDA
approval
· 2022-05-02
FDA Approved: BORTEZOMIB — Original Application (Fresenius Kabi USA, LLC)
Summary
FDA approves Fresenius Kabi USA's generic bortezomib injection under Original Application. Indications include multiple myeloma and mantle cell lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BORTEZOMIB (BORTEZOMIB)